Liste des publications

Toutes les publications des équipes du C3M.

Exporter en CSV
Paternal peri-conceptional physical activity and the risk of congenital heart disease in offspring: A case-control study.

Auteurs Atieh O, Azzi NMJ, Lteif GJ, Atieh NA, Germanos NY, Grandjean V, Yarkiner Z, Saliba Z, Khalife MF, Raad G

Andrology Apr 2024

The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitntriors.

Auteurs Muller C, Lacroix-Malgras V, Kluza J, Laine W, Güler Y, Bost F, Boisbrun M, Mazerbourg S, Flament S

Cancer cell international Apr 2024

HSPA8 chaperone complex drives chaperone-mediated autophagy regulation in acute promyelocytic leukemia cell differentiation.

Auteurs Rafiq S, Mungure I, Banz Y, Niklaus NJ, Kaufmann T, Müller S, Jacquel A, Robert G, Auberger P, Torbett BE, Muller S, Tschan MP, Humbert M

Pharmacology Apr 2024

Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.

Auteurs Meierjohann S, Bertolotto C

Signal transduction and targeted therapy Apr 2024

[When ubiquitination intertwines with cutaneous melanoma: a mechanism to explore].

Auteurs Arrighi N, Breda L, Kerdilès T, Meyer C, Prugneau L, Rabatel O, Wagner G, Krossa I, Pisibon C

Medecine sciences : M/S Mar 2024

[PROTAC technology: a promising approach in oncology].

Auteurs Azuaga Moreso M, Bertrand C, Duffrene J, Dumont M, Lecouffe A, Muller C, Arrighi N, Onesto C

Medecine sciences : M/S Mar 2024

[Trained immunity : emerging strategies against antibiotic resistance].

Auteurs Badin L, Franc C, Gilbert P, Magdeleine JJ, Martin L, Vernaz R, Arrighi N, Garcia-Sanchez JA

Medecine sciences : M/S Mar 2024

Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial.

Auteurs Estran S, Loschi M, Benachour S, Soldati A, Chiche E, Sammut R, Robert G, Jacquel A, Chibois J, Schneider S, Cluzeau T

Bone marrow transplantation Mar 2024

Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

Auteurs Montemagno C, Jacquel A, Pandiani C, Rastoin O, Dawaliby R, Schmitt T, Bourgoin M, Palenzuela H, Rossi AL, Ambrosetti D, Durivault J, Luciano F, Borchiellini D, Le Du J, Gonçalves LCP, Auberger P, Benhida R, Kinget L, Beuselinck B, Ronco C, Pagès G, Dufies M

Journal of experimental & clinical cancer research : CR Mar 2024

Mechanisms of melanoma aggressiveness with age.

Auteurs Bertolotto C

Nature aging Mar 2024